+86 19937104978
Author:Kangdi 10-11-2026
Medica vs Canton Fair vs Asia Health 2026: Which Show for Which Buyer, and When the Answer Is None
Three shows, one budget, and a decision that most manufacturers get wrong by treating it as a question of size. This page is a decision framework rather than a comparison table: what each show structurally does, the four questions that route you to one of them, the arithmetic that reveals whether any of them is worth attending, and the specific situations in which the correct answer is to stay home and spend the money on something else.
By the end of this page you will know the structural difference between the three shows, the 4-question routing framework, the realistic cost and return for each, the 5 signals that mean do not attend, and the two-year planning logic that makes one show outperform three.
There is one reframing that changes the decision, and it is worth stating before the comparison: a trade show is a verification channel, not an acquisition channel. It confirms and deepens relationships that already exist in some form, and it converts a name into a face. What it does not do reliably is create demand where none existed, because a visitor who has never heard of you has no reason to spend twenty minutes at your stand when forty other suppliers are within walking distance. A manufacturer who attends a show with no existing customer base and no pre-booked meetings is buying a very expensive form of visibility that produces brochures on other people's shelves.
Bottom line. Choose Medica if your target is European and Gulf distribution and you already have or can pre-book meetings. Choose Canton Fair if your objective is to be seen by Asian and global sourcing buyers and you want volume of exposure rather than depth of conversation. Choose Asia Health if your market is Southeast Asia specifically and you want regional distributors in one place. Choose none of them if you have fewer than fifteen pre-bookable meetings, no product range that is ready to sell, or a first-order value below the show's cost — and spend the same money on referrals, directory presence, and direct outreach, which produce more per euro at that stage.
Table of Contents
- What each show structurally does
- The 4-question routing framework
- Medica: what it is actually for
- Canton Fair: what it is actually for
- Asia Health: what it is actually for
- Realistic cost and return for each
- The three questions to ask before rebooking
- The 5 signals that mean do not attend
- What to spend the money on instead
- The calendar conflict nobody plans for
- The two-year planning logic
- FAQ: show choice questions manufacturers ask most
- About Kangdi Medical and our show calendar
1. What Each Show Structurally Does
The three shows differ less in size than in who attends and why. The table below sets out the structural difference, which is what determines whether a given manufacturer gets value.
| Show | Who attends and why | What it structurally does | What it cannot do |
|---|---|---|---|
| Medica (Dusseldorf, November) | European and Gulf distributors, hospital procurement, pharmacy chains, brand owners seeking private label capacity | Converts an existing relationship into a deeper one, and puts a face to a name that has been emailing | Create demand. The visitor has a category brief and forty suppliers to see |
| Canton Fair (Guangzhou, April and October) | Global sourcing buyers, trading companies, agents, and a large number of curious visitors | Delivers volume of exposure and lets a buyer physically handle product from many factories in one place | Produce depth. The average conversation is short because the visitor is comparing |
| Asia Health (Bangkok, January) | Southeast Asian distributors, pharmacy chains, hospital procurement across 11 markets | Puts regional distributors from several countries in one room, which is otherwise a multi-trip exercise | Reach beyond the region. European and Gulf attendance is limited |
The row that matters most is the "what it cannot do" column. A manufacturer who expects Medica to generate new leads from companies that have never heard of them will be disappointed, not because Medica is a bad show but because a trade show is structurally a verification channel. The visitors who produce orders are the ones who came with a reason to find you.
2. The 4-Question Routing Framework
Four questions, answered in order, route a manufacturer to the right show or to none.
| # | Question | If yes | If no |
|---|---|---|---|
| 1 | Do you have at least fifteen named contacts who would plausibly agree to a meeting? | Continue to question 2 | Do not attend any show. The pre-booking problem is the whole problem |
| 2 | Is your primary target market Europe or the Gulf? | Medica | Continue to question 3 |
| 3 | Is your primary target market Southeast Asia? | Asia Health | Continue to question 4 |
| 4 | Is your objective to be seen by a broad sourcing audience rather than to close? | Canton Fair | Do not attend; the objective is unclear |
Question 1 is the one that disqualifies most programmes, and it is worth being strict about. Fifteen named contacts is a low bar, and a manufacturer who cannot reach it has not done the pre-show work that makes the show worthwhile. Attending anyway produces the most expensive possible outcome: a stand, a travel budget, and a week of senior time, in exchange for a stack of cards from people who had no reason to be there.
Question 4 is the one that is usually answered dishonestly. A manufacturer who says the objective is to close, and then chooses Canton Fair, has chosen a show whose structure is exposure rather than depth. That is not wrong, but it should be a conscious choice about what the money buys.
3. Medica: What It Is Actually For
| Dimension | Detail |
|---|---|
| Best for | A manufacturer with 20-40 pre-bookable European or Gulf meetings, and a product range that is ready to sell rather than in development |
| What a good show looks like | 15-25 substantial conversations, 3-8 quotations issued within two weeks, 1-3 trial orders within three months |
| What a bad show looks like | Sixty cards, four replies, and a conclusion that exhibitions do not work |
| The structural advantage | Visitors arrive with a specific reason. The category is not central to Medica, which filters out the casual browsers |
| The structural disadvantage | Expensive, and the visitor's time is divided across forty suppliers |
The structural advantage is worth emphasising because it is counter-intuitive. A show where your category is not the centre of attention sounds like a disadvantage, and it is the opposite for a specialist manufacturer: the visitors who stop are the ones with a specific reason, and there are fewer casual browsers to consume the team's time. A patch manufacturer at a show where patches are one of two hundred categories gets fewer visitors and better ones.
4. Canton Fair: What It Is Actually For
| Dimension | Detail |
|---|---|
| Best for | A manufacturer who wants broad exposure, physically handled product in front of many buyers, and a large number of short conversations |
| What a good show looks like | 80-150 conversations across the phase, 30-50 cards worth following up, and 5-10 that turn into quotations |
| What a bad show looks like | Heavy foot traffic with almost no qualified buyer, because the visitor mix includes many agents and curious parties |
| The structural advantage | Volume and physicality. A buyer can handle your product in the morning and three competitors' in the afternoon |
| The structural disadvantage | Short conversations, and a visitor mix where the proportion of real buyers is lower than at a specialist show |
The physicality advantage is real and underrated. A buyer comparing patch adhesion across five factories in one day learns something that no brochure conveys, and a manufacturer whose product is genuinely better in the hand benefits from that comparison more than from any presentation. A manufacturer whose product is merely adequate benefits less, because the comparison is the whole point of the visit.
5. Asia Health: What It Is Actually For
| Dimension | Detail |
|---|---|
| Best for | A manufacturer whose primary market is Southeast Asia and who needs regional distributors in several countries at once |
| What a good show looks like | 20-40 conversations with distributors from 5-8 countries, and 2-4 country-level distribution discussions |
| What a bad show looks like | A regional audience for a manufacturer whose target market is elsewhere, which is a mismatch rather than a failure |
| The structural advantage | Regional density. Distributors from Indonesia, Thailand, Vietnam, the Philippines, and Malaysia in one place, which is otherwise five trips |
| The structural disadvantage | Price sensitivity. Southeast Asian distributors are highly price-comparative, which compresses margin |
The price sensitivity point is the one to weigh honestly. A manufacturer whose value proposition is a premium, documented, defensible product will find the conversations harder at Asia Health than at Medica, because the regional buyer's first question is often the price. That does not make the show wrong; it makes it suited to a different positioning.
6. Realistic Cost and Return for Each
| Item | Medica | Canton Fair | Asia Health |
|---|---|---|---|
| Stand space, 12-18 sqm | EUR 4,000-9,000 | USD 2,500-6,000 | USD 2,000-4,500 |
| Stand build | EUR 3,000-12,000 | USD 1,500-5,000 | USD 1,500-4,000 |
| Travel and accommodation, 3 people | EUR 4,000-7,000 | USD 2,000-4,000 | USD 2,500-4,500 |
| Samples and print | EUR 800-2,500 | USD 500-1,500 | USD 400-1,200 |
| Total | EUR 12,000-31,000 | USD 6,500-16,500 | USD 6,400-14,200 |
| Realistic qualified follow-ups | 15-25 | 30-50 | 20-40 |
| Realistic first orders in 6 months | 2-6 | 2-8 | 2-5 |
| Cost per qualified follow-up | EUR 500-1,900 | USD 130-550 | USD 160-710 |
The last row is the most useful comparison and the one most often omitted. Medica produces better conversations but at a much higher cost per conversation; Canton Fair produces more conversations at a lower unit cost. The right choice depends on which of those two numbers matters for the stage the manufacturer is at, and the answer is not the same at every stage.
A manufacturer with a proven product and a defined target market should pay for Medica's cost per conversation, because a few deep relationships are worth more than many shallow ones. A manufacturer still establishing exposure should pay for Canton Fair's unit economics, because the objective at that stage is to be known rather than to close.
7. The Three Questions to Ask Before Rebooking
Most manufacturers rebook the same show every year without asking whether the previous year produced anything. Three questions, answered with actual numbers, prevent that habit.
| # | Question | What a good answer means | What a bad answer means |
|---|---|---|---|
| 1 | How many of last year's follow-ups became a quotation? | Roughly 30-50% of the qualified follow-ups | Under 20%, which usually indicates the qualification on the stand was wrong |
| 2 | How many of those quotations became a first order? | 20-30%, within six months | Under 10%, which indicates a pricing or specification mismatch rather than a show problem |
| 3 | What was the revenue from those first orders, against the show cost? | Three times the show cost or more, at the twelve-month mark | Below the show cost, which means the arithmetic does not work at your order size |
Question 3 is the one that decides rebooking, and it needs a twelve-month window rather than a three-month one, because a B2B first order rarely lands inside a quarter. A manufacturer who judges a show after three months will almost always conclude it failed, because the follow-up sequence alone takes sixty days.
The bad answer in question 1 is the most actionable, because it points at the stand rather than at the market. If the follow-ups are qualified but the quotations are few, the qualification on the stand was too generous, and the fix is the grading discipline rather than a different show. A manufacturer who changes shows without fixing the qualification problem reproduces it in a different city.
8. The 5 Signals That Mean Do Not Attend
| # | Signal | Why it is disqualifying |
|---|---|---|
| 1 | Fewer than fifteen pre-bookable meetings | The show is a verification channel and there is nothing to verify |
| 2 | The product range is still in development | You will show a prototype to people who buy finished products, and the follow-up has nothing to send |
| 3 | No one on the team can answer a technical question | The conversations that matter are technical, and a sales-only team converts them into cards rather than orders |
| 4 | The show cost exceeds the value of a typical first order | The arithmetic cannot work at that scale, regardless of how good the show is |
| 5 | No capacity to follow up within seventy-two hours | The sequence is worth more than the stand, and a team that cannot send emails 1 and 2 will not realise the investment |
Signal 4 is worth calculating explicitly. A manufacturer whose typical first order is USD 8,000 should not spend USD 15,000 on a stand, because even a good show does not produce enough first orders to repay the cost in the first year. The same money spent on referrals, directory presence, and direct outreach produces more per dollar at that order size, though less visibly.
9. What to Spend the Money on Instead
| Alternative | Cost | What it produces |
|---|---|---|
| Referral programme with existing customers | A commission or a discount | The highest-converting lead source in this category, at a fraction of the show cost |
| Directory and certification register presence | Free to a few hundred dollars | Verifiable entity signals that produce enquiries continuously |
| A factory visit programme for ten target distributors | Travel and hosting | Deeper than a show conversation, because the visitor sees the line |
| Direct outreach with a specific offer | Time, and a sample budget | A measurable pipeline at a known cost per enquiry |
The factory visit row is the one that most manufacturers under-use. A distributor who spends a day at the plant sees the coating line, the lab, and the record room, which is a stronger basis for a relationship than a twenty-minute stand conversation in a hall with forty competitors. Hosting ten distributors over a year costs less than one Medica stand and produces conversations that are deeper.
10. The Calendar Conflict Nobody Plans For
The 2026 calendar creates a specific problem that no comparison table captures: Canton Fair Phase 3 and Medica overlap. The Guangzhou phase runs 14-18 November and Medica runs 17-20 November, which means a manufacturer cannot do both without splitting a team.
| Option | What it involves | When it works |
|---|---|---|
| Split the team | Two people in Guangzhou for days 14-18, two in Dusseldorf for days 17-20, with the senior person travelling between | When both markets are genuinely active and the manufacturer has depth of staff |
| Exhibit at one, visit the other | A stand at Medica, and a one-day visit to Guangzhou on the 14th or 15th before flying | The most common solution, and the one that produces a usable outcome for both |
| Choose one, skip the other this year | Full commitment to one, with the other deferred to the next cycle | When the target market is clearly one or the other, which is the honest answer for most manufacturers |
| Skip both | The recommendation in Section 8 for a manufacturer below the threshold | When the pre-booking test fails, and the overlap makes the wrong choice twice as expensive |
The split-team option looks attractive and is usually the weakest of the four, because the senior person spends two days in transit and neither team has the decision-maker it needs. A stand staffed by two people who cannot agree a price or a lead time produces cards rather than orders, and the travel cost of the split is roughly the cost of a third stand.
The "visit one, exhibit at the other" option is the practical answer for a manufacturer with active business in both regions. A single day at Guangzhou, arriving on the 14th and leaving on the 16th, covers the aisles, produces fifteen to twenty conversations, and puts the manufacturer in Dusseldorf for the full Medica run. The cost is one flight and two hotel nights, which is a fraction of a second stand.
The calendar conflict also explains why the two-year logic matters more than it appears. A manufacturer who tries to do both every year splits attention, and the split shows up as weak performance at each. A manufacturer who alternates, or who exhibits at one and visits the other, produces a stronger result at both over two years than a manufacturer who splits the team annually.
11. The Two-Year Planning Logic
| Year | Objective | Show choice |
|---|---|---|
| Year 1 | Be known, build the contact base, and learn which markets respond | Canton Fair or Asia Health, at the lower unit cost, with a deliberate focus on collecting qualified contacts |
| Year 2 | Convert the contact base into relationships | Medica, with 20-40 pre-booked meetings drawn from the year-one contacts plus referrals |
| Ongoing | Maintain presence without repeating the full cost | Attend as a visitor with a pre-booked meeting schedule rather than exhibiting, which costs a fraction and preserves the relationships |
The ongoing row is the one that most manufacturers never consider. After two years of exhibiting, a manufacturer has a base of relationships that can be maintained by attending as a visitor with ten pre-booked meetings. That costs a badge and a flight rather than a stand and a build, and for a manufacturer whose objective is relationship maintenance rather than new exposure, it is the better use of the budget.
12. FAQ: Show Choice Questions Manufacturers Ask Most
10.1 Which show should a first-time exhibitor choose?
Canton Fair or Asia Health, depending on the target market, because the cost per conversation is lower and the objective at that stage is to be known. Medica is better as a second or third show, once there is a contact base to pre-book meetings with.
10.2 Is Medica worth three times the cost of Canton Fair?
Only if the conversations convert at three times the rate, which they do for a manufacturer with a proven product and an established European or Gulf target. For a manufacturer still building exposure, the arithmetic does not work and the cheaper show is the correct answer.
10.3 Can I attend a show without exhibiting?
Yes, and for relationship maintenance it is the better option. A badge and a flight cost a fraction of a stand, and ten pre-booked meetings in the show's meeting areas produce most of the value of exhibiting without the build cost.
10.4 How many shows should we attend per year?
One, for most manufacturers. Two is defensible if the target markets are genuinely different (Europe and Southeast Asia, for example). Three or more usually indicates an unclear market focus rather than ambition.
10.5 What if our typical first order is small?
Then the show arithmetic does not work, and the money is better spent elsewhere. A manufacturer with an USD 8,000 first order should not spend USD 15,000 on a stand; referrals, directory presence, and a factory visit programme produce more at that scale.
10.6 Does exhibiting help with online visibility?
Indirectly. An exhibitor listing is a corroborating source for entity work, and it stays online for a year or more. That value is real but small compared with the commercial value of the conversations, and it should not be the reason to exhibit.
10.7 What is the single most common mistake in show choice?
Choosing by size. A manufacturer who picks the largest show because it is the largest has not asked whether the visitor profile matches the target market, whether the cost per conversation can be justified, or whether there are enough pre-bookable contacts to make the stand worthwhile.
10.8 Should we exhibit at both Canton Fair phases?
No. Phase 3 is the medical and health products phase, and exhibiting in a different phase means exhibiting to a visitor group with no interest in your category. Choose the phase that matches the product.
10.9 How do we decide between Asia Health and Medica for a Gulf market?
Medica, because Gulf attendance at Medica is substantial and Asia Health is regional to Southeast Asia. Asia Health is the right choice only if the target is the Southeast Asian market itself.
10.10 What does Kangdi do?
We exhibit at Canton Fair Phase 3 and at Medica, and we attend Asia Health as a visitor with pre-booked meetings when the Southeast Asian pipeline justifies it. Send us a note with "Show Choice" and your target markets, and we will tell you which of the three we would choose for a manufacturer in your position, including the case where the answer is none of them.
13. About Kangdi Medical and Our Show Calendar
Henan Kangdi Medical Devices Co., Ltd has manufactured transdermal patches since 1989 at a GMP-certified facility in Zhoukou, Henan, China, and we ship to 200+ brand buyers and distributors across 40+ countries. Our show calendar follows the two-year logic described here, and we treat the decision of which show to attend as a budget allocation rather than a habit.
Three steps to get a show recommendation. (1) Email us with "Show Choice" as the subject line, including your target markets, your typical first-order value, and the number of contacts you could plausibly pre-book. (2) We will tell you which of the three we would choose for your position, or whether the answer is to attend none of them. (3) If a show is the right answer, we will share the pre-booking sequence and the stand staffing model we use.
- Step 1: Email export@kangdimedical.com with "Show Choice" as the subject line, including target markets, first-order value, and pre-bookable contacts.
- Step 2: Receive the recommendation within 3 business days, including the "none of them" case if it applies.
- Step 3: Get the pre-booking sequence and stand staffing model for the show chosen.
Tell us your target markets, your typical first-order value, and how many contacts you could pre-book, and we will send the recommendation within 3 business days.